8-K: NeurAxis, Inc. Grants Stock Awards to Non-Employee Directors

NeurAxis, Inc. granted unrestricted stock awards to its three non-employee directors as compensation for past services, marking the first issuance under its 2022 Omnibus Securities and Incentive Plan since its IPO.

Summary

• NeurAxis, Inc. granted shares of common stock to its three non-employee directors, Kristin Ferge, Beth Keyser, and Bradley Mitch Watkins, on June 28, 2024.
• The shares were granted as unrestricted stock awards under the company's 2022 Omnibus Securities and Incentive Plan.
• This is the first issuance of securities under the plan since the company's initial public offering in August 2023.
• The shares were granted as compensation for services provided by the directors through March 31, 2024.
• The number of shares granted was determined by dividing the amount owed to each director by the closing price of the common stock on June 28th, which was $2.78 per share.
• The company has agreed to issue shares of common stock with a value of $12,500 per quarter to each non-employee director, totaling $50,000 per year in equity compensation.
• Each director entered into an unrestricted stock award agreement with the company on July 1, 2024.
• The company plans to use this form of agreement for all future unrestricted stock awards under the plan.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate practice of granting stock awards to directors, which is generally viewed positively as it aligns interests. There are no significant negative implications, but it is not a major positive catalyst either.

Positives

• The stock awards align director compensation with company performance.
• The use of equity-based compensation may help conserve cash.
• The company has a clear plan for future stock awards to non-employee directors.

Risks

• The issuance of new shares could potentially dilute existing shareholders.
• The value of the stock awards is subject to market fluctuations.

Future Outlook

The company plans to use the same form of Unrestricted Stock Award Agreement for all future unrestricted stock awards issued under Article IX of the Plan.

Management Comments

• The Board of Directors granted shares of common stock to the three non-employee directors as compensation for their services.

Industry Context

Granting stock awards to non-employee directors is a common practice to align their interests with those of the shareholders and to conserve cash, particularly for companies that have recently gone public.

Comparison to Industry Standards

• Many companies, especially those in the technology and biotech sectors, use stock awards as part of their compensation packages for non-employee directors.
• The amount of equity compensation varies widely based on the company's size, stage, and industry, but $50,000 per year is within the typical range for smaller public companies.
• The use of a standard form of agreement for all stock awards is a common practice to ensure consistency and compliance.

Stakeholder Impact

• Shareholders may experience slight dilution due to the issuance of new shares.
• Non-employee directors are incentivized to act in the best interests of the company through equity ownership.

Next Steps

• The company will continue to issue quarterly stock awards to non-employee directors.
• The company will use the same form of Unrestricted Stock Award Agreement for future grants.

Key Dates

Keywords

stock awards, non-employee directors, equity compensation, share issuance, incentive plan, NeurAxis